SCHEMBL9622865

SCHEMBL9622865

CNc1ccc(N)c(C(=O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
KMT2A Q03164 3/20 0.57
GFER P55789 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
ALDH1A1 P00352 4/20 0.56
CDC25B P30305 1/20 0.56
CASP6 P55212 1/20 0.56
RCE1 Q9Y256 1/20 0.56
MAPT P10636 5/20 0.55
TDP1 Q9NUW8 4/20 0.55
POLB P06746 4/20 0.55
MEN1 O00255 2/20 0.55
MCL1 Q07820 2/20 0.55
USP2 O75604 1/20 0.55
THRB P10828 1/20 0.55
PKM P14618 1/20 0.55
APEX1 P27695 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
GLA P06280 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774946 0.85 IKBKB (0.49) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL21230658 0.82 KDM4E (0.59) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL709947 0.82 HSD17B10 (0.47) KDM4EKMT2AALDH1A1CDC25BMAPT
SCHEMBL258439 0.81 MYC (0.56) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL31597491 0.81 MYC (0.56) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL23517113 0.81 KDM4E (0.53) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL2030008 0.81 MYC (0.56) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL10625157 0.81 KMT2A (0.57) KDM4EKMT2AGFERRXFP1ALDH1A1
SCHEMBL17774904 0.80 MAP4K1 (0.45) KDM4EALDH1A1MAPTALOX15GAA
SCHEMBL17118247 0.80 F3 (0.44) KDM4EALDH1A1MAPTTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362244-A1 PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. 2017-12-21 US disclosed
US-8486938-B2 Pyrazolo[1,5-a]pyrimidines for antiviral treatment GILEAD SCIENCES, INC. (US) 2013-07-16 US disclosed
EP-0280187-B1 HAIR DYEING COMPOSITIONS WITH DIRECT-DYEING NITRO-DIPHENYL AMINE DERIVATIVES Henkel Kommanditgesellschaft auf Aktien (DE) 1992-01-02 EP disclosed
EP-0280187-A1 Hair dyeing compositions with direct-dyeing nitro-diphenyl amine derivatives Henkel Kommanditgesellschaft auf Aktien (DE) 1988-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362244-A1 PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT TYMP, ZC3HAV1, TYMS KDM4E 2069/4885KMT2A 3648/4885GFER 4522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.